Name: UPDATE: Top US vaccine expert says he was ‘forced out’ of federal agency
Brand: ajc.com
SKU: ajc-com-47
Availability: OnlineOnly

critic

UPDATE: Top US vaccine expert says he was ‘forced out’ of federal agency

preview

One of the nation’s top vaccine development experts said he was&nbsp;“forced out” of a federal agency, according to New York Times reporter Maggie Haberman.SCOOP - Dr. Rick Bright says in statement he was pushed out of BARDA for a narrower, more limited role at NIH for wanting to use science to test treatments for COVID19, specifically the administration push to get chloroquines in wide use https://t.co/T6DHLIYWnC— (@maggieNYT)Rick Bright, who was the director of the Biomedical Advanced Research and Development Authority (BARDA), said he was pushed out for wanting to use science to test treatments for COVID-19, specifically the Trump administration’s push to get chloroquines in wide use, Haberman reported.The agency is part of the U.S. Department of Health and Human Services and,&nbsp;, was established to protect the nation&nbsp;"from chemical, biological, radiological, and nuclear threats, as well as from pandemic influenza (PI) and emerging infectious diseases."»Bright, according to&nbsp;, is moving into a smaller role at the National Institutes of Health. Gary Disbrow, Bright's former deputy, will serve as the acting director of the office, an HHS spokesperson said.&nbsp;Bright has also worked for the Atlanta-based Centers for Disease Control and Prevention and as an adviser to the World Health Organization.BARDA invests in drugs, devices and other technologies that help address infectious disease outbreaks and has been at the center of the federal government’s coronavirus pandemic response.US records lowest coronavirus-related deaths in 2 weeksCongress more than tripled BARDA’s budget in the most recent coronavirus stimulus package. The office has partnered with Johnson &amp; Johnson and Moderna Therapeutics, both of which are developing potential COVID-19 treatments.Johnson &amp; Johnson, while slashing its 2020 sales forecast by billions of dollars and cutting its profit expectations, is aiming to have its single-dose vaccine candidate available for broad use early in 2021.FDA clears first COVID-19 saliva testIt also is testing two backup vaccine candidates. The company has a long track record on vaccines, developing ones for HIV, Ebola and the Zika virus during the last decade.BARDA’s director reports directly to the HHS assistant secretary for preparedness and response.Rich Barak of The Atlanta Journal-Constitution contributed to this report.About the AuthorEditors' PicksThe LatestFeatured© 2022 The Atlanta Journal-Constitution. All Rights Reserved. By using this website, you accept the terms of our , , , and understand your options regarding .

One of the nation’s top vaccine development experts said he was&nbsp;“forced out” of a federal agency, according to New York Times reporter Maggie Haberman.SCOOP - Dr. Rick Bright says in statement he was pushed out of BARDA for a narrower, more limited role at NIH for wanting to use science to test treatments for COVID19, specifically the administration push to get chloroquines in wide use https://t.co/T6DHLIYWnC— (@maggieNYT)Rick Bright, who was the director of the Biomedical Advanced Research and Development Authority (BARDA), said he was pushed out for wanting to use science to test...

public

Tim Darnell

Our mission is to report what’s really going on in your community. We uncover the truth, protect the public’s right to know and hold community leaders accountable for serving the public. We document our region’s moments, milestones and people. Every day, we inform and empower our readers who value credible, in-depth journalism. By providing this important public service, we ultimately help to build a better metro Atlanta and Georgia for the next generation.

ajc.com

Credible

Speculation

Anecdotal Evidence

Generalization

Stacking the Deck

Appeal to Authority

Straw Man

Slippery Slope

Emotional Appeal

Red Herring

False Dilemma

Illogical

Moral Equivalency

Ad Hominem

Correlation w/o Causation

Semantics

Begging the Question

Faulty Analogy

Non Sequitur

Bandwagon

Dogmatism

Failing Occam's Razor

Biased

Pure Opinion

Hit Piece

Racial Bias

National Bias

Religious Bias

Financial Incentive

Political Agenda

Gender Bias

Misused Image/Video

Study Misinterpreted

Mistake

Misused Term

Science Misrepresented

Factual Error

Satire

Surface Level

Lack of Reliable Sources

Sensational

Not Credible

Investigative

Balanced

Well Sourced

Great Context

sports

entertainment

U.S.

international

business

technology

science

culture

politics

media

health

UPDATE: Top US vaccine expert says he was ‘forced out’ of federal agency

No article scores yet.

CRITIC REVIEWS

PUBLIC REVIEWS